Overview

Efficacy and Safety of 5 mg Sublingual Zolpidem vs 10mg Oral Zolpidem in the Induction and Maintenance of Sleep in Patients With Primary Insomnia

Status:
Completed

Trial end date:
2013-12-10

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy and safety of sublingual zolpidem presentation 5 mg in the induction of sleep in patients with primary insomnia.

Phase:

Phase 4

Details

Lead Sponsor:

EMS

Collaborator:

Associação Fundo de Incentivo à Pesquisa

Treatments:

Zolpidem